<DOC>
	<DOCNO>NCT00043368</DOCNO>
	<brief_summary>This protocol allow patient complete Coley oncology study use PF-3512676 ( CPG 7909 ) Injection continue receive treatment disease progression .</brief_summary>
	<brief_title>PF-3512676 ( CPG 7909 ) Injection For Patients Who Completed An Oncology Study Using PF-3512676 ( CPG 7909 )</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<criteria>Immediate ( within 4 week ) prior completion clinical trial PF3512676 Injection alone combination antineoplastic treatment malignancy . The patient receive antineoplastic therapy since complete prior trial PF3512676 Injection , participate another clinical trial follow participation trial PF3512676 Injection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>CPG 7909 continuation study</keyword>
</DOC>